The compound has not been subjected towards the demanding clinical screening demanded for approval by regulatory bodies like the FDA, which means its safety and success in treating medical situations continue to be unproven. Nociceptive Pathways: Investigate indicates that conolidine may affect nociceptive pathways, pathways that carry pain alerts https://seang531uyr6.wssblogs.com/profile